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The LCOT is a self-administered test designed to assess olfactory deficits. Altogether, 525 subjects contributed to the validation.
Elderly participants were well represented in this sample. In a validation study (study 1), 407 healthy and 17 anosmic volunteers
between 15 and 91 years of age underwent threshold, supraliminal detection, and identification testing. Cutoff values for
normosmia and hyposmia were calculated and applied in a second study in a group of patients with smell complaints and in a
group of Alzheimer patients with age-matched controls. Incidence of smell deficit was estimated at 5.6% in the healthy population
of study 1, and at 16% in the elderly control group of study 2. Assessment of the ability of each subtest to discriminate between
groups showed that LCOT is relevant to differentiating between perception and identification deficits and between Alzheimer’s
and hyposmic patients.
1. Introduction
Smell is a key to our relationship to food, approach/avoid-
ance behavior, and alarm response to dangerous chemicals
[1]. Quality of life in general is partly dependent on the
ability to smell, as shown by the complaints of patients
experiencing loss of olfactory sensitivity: mood swings or
depression, and worries about personal hygiene, safety, social
interaction, and so forth, (see [2] for a review). Although
epidemiological surveys were conducted in Sweden [3], the
USA [4], Germany [5], and Australia [6], the frequency of
olfactory dysfunction remains poorly documented in the
French population. The prime aim of this study was therefore
to provide a tool to measure this prevalence.
In recent decades, several olfactory tests were designed
in various countries (see [7]). Some measured identification
only [8–10], some sensitivity only [11], others combined
both [7, 12–15], and one added a discrimination measure-
ment [14]. Thus, the different commercially available tests
do not specifically measure the same olfactory competencies,
but all are designed to detect hyposmia or anosmia.
With hyposmia being operationally described as an
impairment of both sensitivity and quality perception [12],
we wanted a clinical test that would measure both. Each
addresses different competencies: whereas sensitivity reflects
perceptual processes that do not strongly depend on lan-
guage abilities, identification relies on language and culture.
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Cultural variation conditions odor identification, which is
based on learning of odors that have become familiar and
“ecologically valid” [16]; such familiarity varies from country
to country [17–19], as does stimulus typicality for a given
target odor [20]. These considerations led Doty et al. [21],
for example, to modify the American UPSIT test for use
in Asia and Europe. In the European Test of Olfactory
Capabilities (ETOC), odorants were selected so as to reduce
cultural differences in familiarity across countries [7, 22].
The importance of language in odor perception is well
known [23], and a requisite of identification tests is to help
identification by providing participants with several names
in a forced-choice paradigm [16]. Closer examination of
these semantic cues shows that the choice of appropriate
labels is a decisive factor in successful identification [24].
Thus, a second prerequisite for our clinical test was the
ecological validity of the odorants and of their names for a
French population.
One of the prominent causes of impaired smell ability
is aging: this decrease in olfactory function during normal
aging is called presbyosmia [25, 26]. It was therefore
important to collect data from healthy subjects in all age
groups from 15 to 90 years in order to establish normative
lifespan data for both sexes. Such control data were required
in order to be able to compare patient groups to the general
population.
Because clinicians need a short self-administered test
of olfactory function, the Lyon Clinical Olfactory Test was
designed with 3 main purposes:
(1) to describe the sensitivity and identification abilities
of the French population by combining subtests
based on perceptual and cognitive abilities so as to
help orient clinicians towards a central or peripheral
hypothesis in case of olfactory loss; the test, therefore,
crossed 3 types of measurement: threshold, supralim-
inal detection, and identification. This approach was
intended to allow differentiation between problems
of sensitivity and of naming and to be useful in
patients with cognitive deficits;
(2) to categorize the population into 3 classes (nor-
mosmic, hyposmic, and anosmic) by establishing
cutoff values;
(3) to validate the test and the derived norms by
test-retest measurement and application to patient
populations: one sample of patients with Alzheimer’s
disease and another of patients from our smell clinic.
2. Materials and Methods
2.1. Principle. The Lyon Clinical Olfactory Test (LCOT) is
composed of blocks of four 15mL vials [22, 27, 28]. Only 1
of the 4 contains an odorant, dissolved in odorless mineral
oil (Sigma-Aldrich) soaked up on oil-absorbent to avoid
any leakage during vial opening and to increase the area of
exchange with the air. The other vials are blanks containing
only the mineral oil solvent soaked up on the oil-absorbent.
The whole procedure is based on 4 alternative forced choices
(4-AFC).
Testing consisted of 3 tasks: threshold detection, supral-
iminal detection, and identification.
Threshold Measurements used 2 different odorants:
R-(+)-carvone (minty odor, Sigma-Aldrich) and tetrahy-
drothiophene (THT, gas odor and Euracli). These familiar
and thus “ecological” odorants were used instead of the
classical l-butanol because the latter also stimulates the
trigeminal nerve [29]. Moreover, using the familiar main
gas odor was relevant for the clinicians, who could warn
people when they did not detect it. The same threshold
determination procedure was used for both compounds:
5 concentration levels were presented, from weakest to
strongest (dilution factor: 10), with a forced choice paradigm
(ascending staircase 4-AFC procedure). For each block,
subjects were told to smell the 4 vials consecutively and to
indicate on a response sheet which one smelled strongest
or else, if they did not smell any difference between the
vials, to guess (4-AFC). No feedback on response correctness
was given. The blocks were presented in increasing order
of concentration: 10−6, 10−5, 10−4, 10−3and 10−2 (vol./vol.)
for R-(+)-carvone and 10−7, 10−6, 10−5, 10−4 and 10−3
(vol./vol.) for THT.
Supraliminal Detection and IdentificationMeasurements
used a series of 16 odorants, diluted at an easily detectable
concentration level (around 10−2) (Table 1).
Following the same 4AFC procedure, subjects were to
smell a block of 4 vials, detect which vial contained an odor,
and then identify the odor by selecting a label among 4
proposed alternatives. For instance, the 4 alternative labels
associated with the lavender stimulus were “leather”, “paint,”
“lavender,” and “almond”. The test was self-administered.
Subjects were given the 26 test blocks (5 for carvone
threshold, 5 for THT threshold, and 16 for suprathreshold
detection and identification), an instruction sheet, and a
response sheet; they recorded their answers by circling their
choice (vial code or label) on the response sheet, with their
age, gender, smoking habits, and possible nasal diseases.
They worked individually under the supervision of a trained
experimenter. The time required to open and close the 4 vials
and to mark the response on the sheet ensured that there was
an interval of at least 45 sec between stimulations, reducing
the risk of adaptation. Testing lasted about 30–35 minutes
per subject.
2.2. Scoring. The threshold score was defined as the lowest
odor concentration detected and followed by correct detec-
tions. Scores ranged from 5 (when the odor was detected
correctly from the weakest concentration) to 1 (when the
odor was detected correctly only at the strongest); subjects
who failed to detect the strongest concentration were scored
0. Two threshold scores were recorded for each subject: R-
(+)-carvone threshold (CT) and THT (gas odor) threshold
(GT), both from 0 to 5.
For each subject, supraliminal detection performance
(DP) was the number of correct detections (from 0 to 16),
identification performance (IP), and the number of correct
responses (from 0 to16). The rationale of this supralim-
inal detection level is that odor identification was scored
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Table 1: List of odorants, origins, and odors. Eur: Euracli; Sig:
Sigma-Aldrich.
Odorant Origin Odor
1,8 cineole Sig Eucalyptol
R-(+)-carvone Sig Carvi
ω-pentadecalactone Sig Musk
Tetra-hydro- thiophene Eur Main gas
Anise essential oil Eur Anise
Apple essential oil Eur Apple
Cinnamon essential oil Eur Cinnamon
Domestic fuel-oil Total Fuel-oil
Garlic essential oil Eur Garlic
Grass aroma Eur Grass
Lavender essential oil Eur Lavender
Lemon essential oil Eur Lemon
Mint essential oil Eur Mint
Orange essential oil Eur Orange
Smoked fish aroma Eur Smoked fish
Vanilla essential oil Eur Vanilla
Violet essential oil Eur Violet
as correct only when the corresponding odor vial was
detected correctly: as the risk of correct detection by chance
and of correct identification by chance was for both 1/4, the
scoring procedure reduced the probability of identifying an
odor by chance to 1/16.
Moreover, because DP measured a perceptual ability and
IP measured a more verbal one, it was hypothesized that the
difference between these scores (DP−IP) could reveal some
cognitive components of olfactory deficit; a differential score
(DD = DP− IP) was therefore calculated (from 0 to 16).
2.3. Odorants. Pure chemical compounds were purchased
from Sigma-Aldrich. Domestic fuel-oil was purchased from
Total. The aromas were kindly provided by Euracli (Chasse-
sur Rhoˆne, France). These smelling compounds were
selected for their high level of familiarity for a French
population [24] (Table 1). They were diluted in mineral oil
(Sigma-Aldrich, 1%), except for ω-pentadecalactone which
was diluted in diethyl phthalate (Sigma-Aldrich, 10%).
3. Study 1
The purpose of study 1 was to determine normative scores
for normosmic, hyposmic, and anosmic subjects, and to
assess test-retest reliability.
3.1. Participants
3.1.1. Healthy Volunteers. Participants were recruited from
volunteers in public sessions organized by Lyon-1 University.
Testing was run in accordance with the Declaration of
Helsinki. Volunteers who presented signs of nasal irritation
or declared olfactory disorder were excluded. Thus, 407
participants between 15 and 91 years of age were included
(Table 2); 92 (23%) were smokers, 221 (54%) had never
smoked, and 94 (23%) were exsmokers. The sex ratio was
61% in favor of women.
3.1.2. Anosmic Volunteers. Seventeen anosmic participants
(10 women), all volunteers, participated. They were diag-
nosed as anosmic according to their medical history, follow-
ing rhinitis, head trauma, or Kallmann syndrome, or without
known etiology. Patients with nasal obstruction at time of
testing were excluded. Ages ranged between 16 and 70 years.
3.2. Test-Retest Sample. Twenty participants (12 women)
from 18 to 59 years of age were retested within a 2-month
interval. Seventeen belonged to the healthy and 3 to the
anosmic sample.
3.3. Statistical Analyses. Regressions and ANOVAs were
performed using SAS release 9.1.3 (SAS Institute Inc., Cary,
NC) and the REG and GLM procedures. The hypothesis tests
on themean of the normal distribution were carried out with
the t-test function of R release 2.12.0 (The R Foundation for
Statistical Computing).
3.4. Results
3.4.1. Healthy Participants. Standardization was based on the
results of the 407 healthy participants; Table 3 presents their
mean scores for each subtest.
To test whether sex and smoking habits influenced
scores on the 5 subtests, 2-way analysis of variance was
performed (Yij = μ + sexi + tobacco j + (sex ¤ tobacco)i j +
εi j , εi jεN(0, σ2)).
For all 5 subtests (CT, GT, DP, IP, and DD), the models
showed no significance at the 5% level, indicating no
influence of sex or smoking habits on test performance.
To assess the influence of age on the scores of healthy
participants, regression analysis was performed (Yi = a +
b · agei + εi, εi ∼ N(0, σ2)). One regression was carried out
for each subtest (CT, GT, DP, IP, and DD). The effect of age
was tested using the Fisher statistic ((H0): b = 0 against (H1):
b /= 0). Results are presented in Table 4.
Age had no significant effect on CT and GT threshold
scores, but significantly influenced IP, DP, and DD scores
(α < 0.0001). CT score distribution was not normal: 34
subjects scored 0 or 1; this represented 8.4% of the tested
population, in agreement with the percentage of specific
hyposmia to R-(+)-carvone in the general population [30];
the CT score was therefore discarded for normative data
calculation. As age did not influence GT score, we looked for
the lower limit of this subtest score for healthy participants.
Given the mean GT score of 3.97, a Student’s t-test was
used to determine whether healthy participants could score
lower than 3 (H0: GT ≤ 3 against H1: GT > 3); results
indicated that healthy participants statistically scored at least
4 (df = 406, t = 5.9, P ≤ 0.0001). As age influenced
DP and IP scores, we looked for the lower limit of each
subtest score according to age. For DP, a Student’s t-
test was used to determine whether healthy participants
4 International Journal of Otolaryngology
Table 2: Distribution of the 407 healthy participants by age group.
Age group (years)
<20 20–29 30–39 40–49 50–59 60–69 70–79 ≥80
N 13 129 44 58 37 50 45 31
% Women 62% 65% 55% 45% 59% 60% 62% 81%
Table 3: Mean scores and standard deviations for 407 healthy
participants.
Carvone threshold (CT) 3.36± 1.24
Gas threshold (GT) 3.97± 0.87
Detection performance (DP) 15.5± 0.9
Identification performance (IP) 14.1± 2.0
Difference (DD = DP− IP) 1.47± 1.74
Table 4: Influence of age on subtest scores (Fisher statistic).
Variable B F-statistic P-value
CT −0.004 2.6 0.10
GT −0.001 0.53 0.47
DP −0.01 24.2 <0.0001
IP −0.05 145 <0.0001
DD 0.04 119 <0.0001
between 15 and 71 years of age could score lower than 14
(age ∈ [15 : 71], H0: DP ≥ 14 against H1: DP < 14); results
showed that they detected at least 14 odors (df = 338, t =
44.3, and P = 1), whereas healthy participants older than 72
years detected at least 13 odors (age ∈ [72 : 91], H0: DP ≥ 13
against H1: DP < 13; df = 62, t = 11.7, P = 1).
The same procedure applied to IP scores showed that
healthy participants between 15 and 64 years of age identified
at least 13 odors (age ∈ [15 : 64], H0: IP ≥ 13 against H1:
IP < 13; t-value = 65.9, df = 304, P = 1), compared to at
least 12 odors between 65 and 74 years of age (age∈ [65 : 74],
H0: IP ≥ 12 against H1: IP < 12; t-value = 36.6, df = 52,
P = 1) and at least 9 odors between 75 and 91 years of
age (age ∈ [75 : 91], H0: IP ≥ 9 against H1: IP < 9; t-value
= 29.97, df = 48, P = 1).
For DD scores, the same procedure indicated that healthy
participants between 15 and 61 years of age obtained a DD
score ≤2 (age ∈ [15 : 61], H0: DD ≤ 2 against H1: DD > 2;
t-value = −14.4, df = 292, P = 1), those between 62 and 71
years ≤4 (age ∈ [62 : 71], H0: DD ≤ 4 against H1: DD > 4;
t-value= −6.9, df = 45, P = 1) and those between 72 and 91
years ≤7 (age ∈ [72 : 91], H0: DD ≤ 7 against H1: DD > 7;
t-value = −13.97, df = 67, P = 1).
3.4.2. Anosmic Participants. Mean scores in the anosmic
patients group were: GT = 0.88 ± 1.05, DP = 4.71 ± 2.28,
IP = 1.42± 1.80, and DD = 3.5± 1.63. These corresponded
to scores expected for random choices. The mean DD score
was higher than in the healthy participants sample: that is,
most of the items detected were not identified. Due to the
small number of patients in anosmic group, the influence
of smoking habits and sex was not tested. To assess the
influence of age, simple regression analysis was performed
(Yi = a+ b · agei + εi, εi ∼ N(0, σ2)) for each subtest (GT, DP,
IP, and DD) and tested on the Fisher statistic ((H0): b = 0
against (H1): b /= 0): age was found not to influence scores, as
none of the 4 regressions were significant (α = 0.05).
The lower limit of each subtest score was determined,
regardless of age: anosmics never scored better than 3 for GT
(H0: GT ≤ 3 against H1: GT > 3; df = 16, t-value = 8.28,
P = 1) and did not detect more than 7 odors (H0: DP ≤ 7
against H1: DP > 7; df = 16, t-value = 4.13, P > 0.99); on IP,
they did not identify more than 5 odors (H0: IP ≤ 5 against
H1: IP > 5; df = 16, t-value = 8.2, P = 1). These scores were
higher than chance, as will be discussed later. DD (i.e., the
difference between DP and IP) did not exceed 5 (H0: DD ≤ 5
against H1: DD > 5; df = 16, t-value = 3.92, P > 0.99).
As shown in Table 5, for this sample of subjects, the
condition, DP ≤ 7, was sufficient to detect anosmics. To
detect normosmics, the conditions DP ≥ 14 for ages [15 : 71]
and DP ≥ 13 for ages >71 were sufficient. By definition,
hyposmics were in between.
GT score was not included in the definition of nor-
mosmia because, according to the confidence limits of the
mean, the scores of the healthy sample ranged from 3.10 to
4.84; thus requiring a GT score of 4 for normosmia would
have categorized as hyposmic many participants who were
within the normal range for the other criteria.
As an internal validation of the normative data is
obtained, the criteria for DP, IP, and DD were applied to
both populations (407 healthy participants and 17 anosmic
patients), with the following results (Table 6).
Twenty three healthy participants were found to differ
from the healthy and anosmic groups and were classified as
hyposmic (5.6%). In the anosmic sample, 1 of the 17 patients
was classified as hyposmic (5.8%).
Figure 1 presents the mean scores of this hyposmic
group, which was composed of 14 women (61%) and 9 men
(39%), with a mean age of 62± 19 years.
The smell problems of these 23 subjects did not concern
supraliminal detection: they detected only 1 odor less than
the whole healthy sample. Their mean thresholds were
moderately lower than those of the 407 healthy subjects:
CT = 3.09 versus 3.36; GT = 3.52 versus 3.97. Therefore,
these 23 subjects seemed to experience mild hyposmia with
moderate reduction in sensitivity. Their main smell problem
resided in identification performance, which was 5 points less
than the sample as a whole (9 versus 14.1), entailing a higher
DD score (5.56 versus 1.47).
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Table 5: Decision table for GT, DP, IP, and DD.
Anosmics Hyposmics Normosmics
GT < 3
DP ≤ 7 8 to 13 for age ∈ [15 : 71], DP ≥ 14
8 to 12 for age ∈ [72 : 91], DP ≥ 13
IP ≤ 5 6 to 12 for age ∈ [15 : 64], IP ≥ 13
6 to 11 for age ∈ [65 : 75], IP ≥ 12
6 to 8 for age ∈ [76 : 91], IP ≥ 9
DD ≤ 5 DD ≥ 3 for age ∈ [15 : 61], DD < 3
DD ≥ 5 for age ∈ [61 : 71], DD < 5
DD ≥ 8 for age ∈ [71 : 91], DD < 8
Table 6: Classification of the population resulting from the cutoff
criteria.
Anosmics Hyposmics Normosmics Total
Normosmic sample 0 23 384 407
Anosmic sample 16 1 0 17
3.5. Test-Retest Reliability. Score repeatability between test
and retest was assessed on binomial test. First, the difference
between the test and retest scores was calculated for each
participant: 0 if the subject obtained the same score twice
(good repeatability) or different from 0 if the scores differed.
If participants responded randomly on test and retest,
the number of 0 differences should follow a binomial
distribution with n = 20 P = 0.2 (in the case of threshold
tests, where scores ranged from 0 to 5) and P = 0.0625 (in
the case of DP and IP, where scores ranged from 0 to 16).
With a P = 0.05 risk level, where P = 0.2, the limit to reject
the null hypothesis is ≥9 and, where P = 0.06, ≥5. The null
hypothesis could thus in the present case be rejected: that
is, test and retest showed significant repeatability (subjects’
scores were not random) at risk level <0.05 for GT and much
less than 0.001 for DP and IP.
3.6. Discussion of Study 1
3.6.1. Normative Data. Other studies define hyposmia in
terms of the 10th percentile’s global score on the olfactory
test (combining threshold, discrimination, and identification
scores) [5, 31] of the performance of patients identified
a priori as anosmic [10] or by comparison (2 standard
deviations) with the performance of healthy subjects under
40 years of age [6]. The present study used scores of
participants who considered themselves either anosmic or
healthy. A statistical approach was used to obtain cut-off
values so that participants whose scores fell in between
could be considered hyposmic. Thus, 5.6% of the healthy
participants without any declared smell problem could be
considered hyposmic.
3.6.2. Threshold Tests. There was no significant effect of
age on CT or GT scores. Those subtests did not strongly
0
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Figure 1: Means and standard errors of scores for the group of
healthy participants classified as hyposmic.
discriminate sensitivity between subjects. This may have
been due to the small number of concentrations used and
the absence of a staircase procedure such as recommended
for precise measurement of thresholds [32]. Another issue
was the high threshold found for l-Carvone in 34 subjects,
which may be explained by a specific hyposmia, resulting
in a bimodal distribution of thresholds [30]. It would then
follow that the carvone threshold is not suitable for screening
sensitivity in the population as a whole. On the other
hand, the threshold for THT (gas odor) alone seemed to be
sufficient to identify anosmics, who scored less than 3. In
detecting hyposmia, a difficulty arose regarding the cut-off
value for GT: a score of 3 would correspond to hyposmia
and a score under 3 to anosmia; but requiring a score of 4
or 5 as a condition for normosmia would result in a large
proportion of hyposmics because the scores of the healthy
sample actually ranged from 3 to 5. The GT score was
therefore discarded from the definition of normosmia and
used only in defining anosmia.
3.6.3. DP Score. The results showed that supraliminal
detection (DP) alone could distinguish normosmics from
hyposmics and anosmics: even the oldest normosmics, over
76 years of age, scored higher than 13; anosmic subjects
did not obtain scores higher than 7. The one subject who
detected 10 odors was therefore classified as hyposmic
according to this cut-off score.
The mean performance of anosmics did not differ from
chance; some odorants, however (eucalyptol, carvone, and
possibly others) included a trigeminal component that could
help some anosmics to detect them above chance level (i.e.,
4/16).
On the basis of our sample of subjects, detection perfor-
mance could be considered as sufficient to categorize subjects
as normosmic or hyposmic. This is an important finding
because this measure is nonverbal, with the advantages
of quick diagnosis and of being independent of culture
and linguistic knowledge. This allows smell deficits to be
diagnosed on a perceptual basis, whatever the language the
subject speaks.
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3.6.4. IP Score. The identification task (IP score) was more
sensitive to age than detection (DP score), indicating a
stronger decrease in cognitive than in perceptual aspects
of smell. It is acknowledged that odor identification is
cognitively demanding [33] and that age impairs both
memory and lexical access to odor names [34, 35].
Overall, the results suggest that some subtests were more
relevant to detecting smell impairment; this is important for
clinicians, who may thus use rapid screening with DP only
when they are short of time. The GT score is relevant to
confirming anosmia and the IP score to assessing distortions
of odor quality.
3.6.5. DD Score. This score also increased with normal
aging: from 2 to 7 between 61 and 91 years. This measure
of cognitive smell impairment was useful in study 2, in
comparison with pathological aging.
3.6.6. Test-Retest. The repeatability of the LCOTwas good: at
a 0.05 risk level for the GT score and considerably less than
0.001 for the CT, DP, and IP scores.
3.6.7. Internal Validity. Classification of anosmic partici-
pants was good, with 5% misclassification, which was the
accepted error risk. The classification of healthy participants
suggested a hyposmia prevalence of 5.6% in a sample
that excluded subjects with smell problems. This is in the
same range as in studies using the tenth percentile of the
population to define hyposmia; nevertheless, the question
remains as to whether this resulted from misclassification
by the statistical model (with an error risk of 5%) or
from correct classification of participants with true smell
deficits. These “healthy” hyposmic participants may have
been unaware of their deficit, or may have suspected it and
volunteered precisely in order to test their sense of smell.
Alternatively, it could be argued that around 10% of the
general population is hyposmic and that a figure of 5.6%
represents a recruitment bias in study 1, which was based on
volunteers.
4. Study 2
The validation study provided norms for the healthy sample
and for anosmics, categorizing individuals scoring between
the cut-off values as hyposmic. Study 2 sought to test the
model and cut-off values on 2 pathological samples: patients
with Alzheimer’s disease (ALZ group) and volunteer smell-
clinic patients complaining of smell troubles (PAT group).
These patient groups were compared with a group of healthy
controls matched for age with the ALZ patients (CONT
group).
4.1. Participants
4.1.1. Olfactory-Impaired Patients. The 36 smell-clinic
patients (22 women) consulted at the olfaction outpatients
department of Edouard Herriot Hospital (Lyon University),
France. Mean age was 51 ± 15 years. Subjects with patent
nasal obstruction or showing abnormal secretion were
excluded.
4.1.2. Alzheimer’s Disease Patients and Control Volunteers.
The Alzheimer’s study was carried out on patients during
day hospital care (Saint Jean de Dieu Hospital, Lyon) (ALZ
group) and on age-matched control volunteers (CONT
group) without known olfactory disorder (often ALZ-
group members’ spouses or main caretakers). Thirty-
three Alzheimer’s patients (28 women; mean age, 77 ± 8
years) and 32 age-matched control volunteers (26 women;
mean age, 76 ± 7 years) participated. Testing was run by
gerontopsychiatrists. Cognitive impairment was measured
in patients and control participants using the Mini-Mental
State Examination (MMSE, [36]). A CT scan was performed
in the Alzheimer’s patients to control vascular dementia,
which was an exclusion criterion. When demented patients
had praxis difficulties, the physician presented the open vials
to the patient and asked: “Does this bottle smell or not?”
In the identification test, a second set of questions was:
“What does it smell of? Does it smell of leather? Does it
smell of paint? Does it smell of lavender? Does it smell
of almond?”, to which patients could answer yes/no; when
patients refused to make any choice between the 4 items, the
investigator randomly attributed one of the four answers.
As regards cognitive impairment, the MMSE scores of the
control (CONT) group were normal (mean ± SD = 29.2 ±
1.2); the ALZ group obtained lower scores with a larger
standard deviation (mean ± SD = 13.0 ± 4.0; range, 5/30 to
21/30). Two-way analysis of variance (age, group) indicated
a significant difference between ALZ and CONT (F = 11.2;
P < 0.001) and no significant effect of age on MMSE score
(F = 0.027, P = 0.97).
4.2. Methods. Statistical analyses were conducted using SAS
release 9.1.3 (SAS Institute Inc., Cary, NC). Analysis of
variance was performed with the GLM procedure followed
by multiple comparison between means (Tukey’s HSD
correction for multiple comparisons). Age was introduced as
a covariate in these analyses. Reported means are least square
means.
4.3. Results
4.3.1. Subject Classification. According to the cut-off scores,
14 PAT group participants were classified as anosmic (39%),
18 as hyposmic (50%), and 4 as normosmic (11%). Accord-
ing to the same rules, the ALZ group comprised 1 anosmic
(3%), 21 hyposmics (64%), and 11 normosmics (33%), and
the CONT group 5 hyposmics (16%) and 27 normosmics
(84%).
Analysis of variance including age as covariate was
carried out for each type of score to assess differences
between the 3 groups (CONT, PAT, and ALZ). Results
consistently showed a significant group effect (GT: F(2, 97) =
6.4, P = 0.003; DP: F(2, 97) = 7.2, P = 0.001; IP: F(2, 97) =
27.3, P < 0.0001; and DD: F(2, 97) = 31.1, P < 0.0001). Age
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Figure 2: Means and standard errors of scores for gas threshold (GT), supraliminal detection (DP), identification (IP), and their difference
(DD) across the 3 groups of study 2 (CONT: control elderly group, ALZ: Alzheimer’s patients, PAT: smell clinic patients). Bars with the same
letter do not differ significantly.
had only a barely significant effect on GT score (F(1, 97) =
4.1, P = 0.046).
4.3.2. Contribution of Each Score to Group Discrimination.
Figure 1 presents the mean scores for each group.
THT threshold (GT) discriminated between groups: the
CONT group scored significantly higher than the PAT and
ALZ groups Figure 2. As regards DP, it is noteworthy that
ALZ patients did not score lower than the age-matched
controls. Only the PAT group detected significantly fewer
odorants, which is a confirmation of lower sensitivity. Iden-
tification performance (IP) discriminated elderly controls
from both PAT and ALZ groups. As hypothesized, the DD
difference between detection and identification scores was
relevant to comparison between different causes of olfactory
impairment: DD was maximum in cognitively impaired
persons, the ALZ group scoring highest, and the CONT
group lowest; the PAT group differed from both ALZ and
CONT. The following cut-off scores may thus be suggested
for DD: with a 95% confidence interval around the mean,
the DD score may be [1−4[ for CONT, [4−6[ for PAT and
[6−8[ for ALZ.
4.4. Discussion of Study 2. Screening 101 new subjects
allowed various degrees of olfactory impairment to be
examined. Normosmia was present in 84% of CONT group
participants, 33% of the ALZ group, and 11% of the PAT
group. The incidence of 16% hyposmia in the CONT group
is in agreement with other studies in older adults [4].
GT, DP, IP, and DD discriminated between smell-
impaired groups. GT discriminated CONT from the PAT
and ALZ groups. More surprisingly, DP, which discriminated
strongly between healthy and anosmic participants in study
1, only separated the PAT group from the others in study
2. One reason may be that this subtest was too easy to be
able to separate different degrees of hyposmia. Identification
performance (IP) uses a more difficult task to match a
verbal description with perceived odor quality, resulting in
larger differences between groups. The DD difference was
lowest in the CONT group, although this group included
16% hyposmics. Thus, the addition of this differential
score improved description of qualitative change in smell
perception with normal aging and various pathologies: DD
was highest in Alzheimer’s patients, which can be interpreted
as a feature of their dementia affecting perceptual less than
cognitive processes.
As underlined, Alzheimer patients did not score lower in
detection performance than age-matched controls, but their
identification scores were in the same range as for the smell-
clinic patients. DD also discriminated these patients from
healthy elderly controls, despite the greater age of the latter.
Comparison of the PAT group with the group of 23
“healthy” hyposmics of study 1 shows that the latter score is
higher on DP and IP, which confirms that they experience a
mild hyposmia. The difference between the PAT group and
the anosmic group of study 1 relies mainly on DP: these
patients detect more odorants than anosmic participants,
which explains why their DD score is also higher.
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5. Conclusion
Altogether, 525 subjects contributed to the validation of
the LCOT. Elderly participants were well represented in this
sample. The incidence of smell deficit was estimated at 5.6%
in the healthy population of study 1 and at 16% in the elderly
control group of study 2. Because the samples were made
up of volunteers, it is difficult to generalize these figures
to the French population as a whole, but they were in the
same range as in other studies [37]. That 16% of subjects
over 60 years of age were found to be hyposmic is, however,
questionable: a number of illnesses and medications are
known to impair olfaction [38, 39]. A norm for healthy
aging should consider only participants in very good health
and without medication; such a procedure strongly reduces
the incidence of smell deficit accompanying normal aging
(presbyosmia) [26]. No effect of smoking was found in the
present as in other studies; sex, however, is frequently found
to influence performance [5, 6]. Because sex differences
mainly concern the verbal performance of women [35], the
present absence of sex effect may be due to the identification
task of the LCOT being rather easy, inducing a ceiling effect.
The present study sought to segregate one olfactory loss
from another, whereas most olfactory tests cumulate subtask
scores. In agreement with Cain et al. [40], the present results
show that detection and identification, when dissociated,
provide different cues for screening the severity of smell
deficit. Supraliminal detection in particular emerged as a
simple tool to classify subjects as anosmic, hyposmic or
normosmic. The DD differential also discriminated between
different smell pathologies.
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